Phase III trial of tesetaxel first-line therapy in advanced gastric cancer

Trial Profile

Phase III trial of tesetaxel first-line therapy in advanced gastric cancer

Planning
Phase of Trial: Phase III

Latest Information Update: 04 Jul 2011

At a glance

  • Drugs Tesetaxel (Primary)
  • Indications Gastric cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors Genta (CEASED)
  • Most Recent Events

    • 04 Jul 2011 New trial record
    • 29 Jun 2011 A phase I/II trial (NCT01348009) will be a 'run-in' for this trial, according to a Genta media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top